endralazine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryFive and 10 mg single oral doses of a new vasodilator antihypertensive, endralazine (E) were given on separate occasions…
SummaryEndralazine (E), a new hydralazine-like antihypertensive was given intravenously (0.05 mg/kg) to 10 normal volunteers (5…
A comparative study of the effects of captopril, an angiotensin converting enzyme inhibitor and endralazine, a new vasodilator…
A comparative, controlled, open hypertension study using the direct vasodilator endralazine and the ACE-inhibitor captopril in…
Endralazine is a peripherally-acting vasodilator with chemical and pharmacological similarities to hydralazine. In both…
This study compared the efficacy of a beta-blocker, pindolol, and a diuretic, clopamide, plus a vasodilator, endralazine, in the…
Unscheduled DNA synthesis (UDS) was assayed by measuring the uptake of 3H-dT into the nucleic DNA of sperm cells of mice during…
Endralazine, a new peripheral vasodilator, was studied in 21 patients with hypertension and chronic renal failure. Nineteen…
Summary We attempted to characterize six vasodilators with respect to their arterial or venous activity by studying their…
SIR: It has been clearly demonstrated that the high density lipoprotein cholesterol (HDL) concentration is a more accurate…